Quantcast
Channel: Sedation Dentist in Palm Desert
Viewing all articles
Browse latest Browse all 1286

Drug Duo May Be a Weapon Against a Common Leukemia

$
0
0
aml cancer cells

The phase 3 trial of more than 500 U.S. patients with chronic lymphocytic leukemia (CLL) found that a combination of rituximab and ibrutinib extended patient survival.


Viewing all articles
Browse latest Browse all 1286

Trending Articles